Search
+
    SEARCHED FOR:

    SHARE ISSUE

    Sanstar's Rs 510-cr IPO to open on July 19; sets price band at Rs 90-95 per share

    Sanstar, a plant-based specialty products company, has set a price range of Rs 90 to Rs 95 per share for its Initial Public Offering (IPO), aiming to raise Rs 510 crore. The IPO will be open for public subscription from July 19 to July 23, as announced by the Ahmedabad-based company.

    3 stocks to trade ex-rights tomorrow. Last opportunity to buy shares

    A rights issue occurs when a company asks its current shareholders to buy additional shares at a discount before a certain date. This gives shareholders the right, but not the obligation, to purchase new shares at a discount to the market price up to a specified future date.

    MM Forgings 1:1 bonus issue: Last day to buy shares to qualify before record date

    MM Forgings' 1:1 bonus share issuance is set for July 16, marking its golden jubilee. Eligible shareholders will receive one bonus share per share, credited by July 28. This, the fourth issuance, capitalizes Rs 24.14 crore from reserves. Q4 2024 saw revenue up 20%, profits up 36%, and shares surged 48%, per Trendlyne. Today is the last qualifying day.

    Effwa Infra and Research stock debuts with 90% premium over issue price

    Effwa Infra Share Price: Effwa Infra and Research's shares debuted on the NSE SME platform with a 90% premium on Friday, opening at Rs 155.8 compared to an issue price of Rs 82. Prior to listing, the company's shares traded at a premium of Rs 74. The IPO, consisting of a fresh equity sale of Rs 43 crore and an Offer for Sale (OFS) of Rs 7.68 crore, garnered strong investor interest, oversubscribing by over 200 times at close.

    What would Hyundai IPO valuation be if priced at par with Maruti Suzuki?

    The upcoming Hyundai Motor India IPO could be priced at different levels, ranging from Rs 1,265 to Rs 1,988 per share. With plans to raise $3.5 billion, the company aims to capitalize on the low-penetrated Indian car market. Valuation concerns compared to global peers have been highlighted by experts.

    Emcure Pharma shares debut with 31% premium over issue price

    Before listing, the company's shares traded at a Rs 360 premium in the grey market. It raised Rs 582 crore from anchor investors, including HDFC MF, ICICI Pru MF, SBI MF, Abu Dhabi Investment Authority, Goldman Sachs Asset Management, Nomura, and HDFC Life. Analysts are bullish on the IPO for listing gains and long-term growth, citing its strong position in domestic therapeutics and expansion plans in India and exports.

    The Economic Times
    BACK TO TOP